PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33704910-0	2021	Trimetazidine improved adriamycin-induced cardiomyopathy by downregulating TNF-alpha, BAX, and VEGF immunoexpression via an antioxidant mechanism.	Trimetazidine	0-13	tumor necrosis factor	Rattus norvegicus	75-84	
27348619-7	2016	TMZ treatment also significantly attenuated CSP-induced oxidative stress and suppressed elevated levels of TNF-alpha and IL-6 and NF-kappaB expression and its DNA-binding activity caused by CSP administration.	Trimetazidine	0-3	tumor necrosis factor	Rattus norvegicus	107-116	
25665480-8	2015	Trimetazidine also significantly decreased the levels of IL-1ss and TNF-a which are the proinflammatory cytokines (p < 0.05).	Trimetazidine	0-13	tumor necrosis factor	Rattus norvegicus	68-73